LT3107B - Transdermal therapeutical system containing fizostigmine and preparation the same - Google Patents

Transdermal therapeutical system containing fizostigmine and preparation the same Download PDF

Info

Publication number
LT3107B
LT3107B LTIP1469A LTIP1469A LT3107B LT 3107 B LT3107 B LT 3107B LT IP1469 A LTIP1469 A LT IP1469A LT IP1469 A LTIP1469 A LT IP1469A LT 3107 B LT3107 B LT 3107B
Authority
LT
Lithuania
Prior art keywords
layer
transdermal therapeutic
physostigmine
therapeutic system
reservoir
Prior art date
Application number
LTIP1469A
Other languages
English (en)
Lithuanian (lt)
Inventor
Lothar Deurer
Thomas Hille
Thomas Profitlich
Fritz Stanislaus
Kersten Walter
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of LTIP1469A publication Critical patent/LTIP1469A/xx
Publication of LT3107B publication Critical patent/LT3107B/lt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
LTIP1469A 1992-11-12 1993-11-12 Transdermal therapeutical system containing fizostigmine and preparation the same LT3107B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4238223A DE4238223C1 (de) 1992-11-12 1992-11-12 Transdermales therapeutisches System zur Verabreichung von Physostigmin an die Haut und Verfahren zu dessen Herstellung

Publications (2)

Publication Number Publication Date
LTIP1469A LTIP1469A (en) 1994-06-15
LT3107B true LT3107B (en) 1994-12-27

Family

ID=6472735

Family Applications (1)

Application Number Title Priority Date Filing Date
LTIP1469A LT3107B (en) 1992-11-12 1993-11-12 Transdermal therapeutical system containing fizostigmine and preparation the same

Country Status (32)

Country Link
US (1) US5698216A (xx)
EP (1) EP0667774B1 (xx)
JP (1) JP3407073B2 (xx)
KR (1) KR100254573B1 (xx)
CN (1) CN1088457A (xx)
AT (1) ATE156356T1 (xx)
AU (1) AU684256B2 (xx)
CA (1) CA2147274C (xx)
CZ (1) CZ284008B6 (xx)
DE (2) DE4238223C1 (xx)
DK (1) DK0667774T3 (xx)
EE (1) EE03135B1 (xx)
EG (1) EG20527A (xx)
ES (1) ES2105334T3 (xx)
FI (1) FI952269A0 (xx)
GR (1) GR3024720T3 (xx)
HR (1) HRP931391B1 (xx)
HU (1) HUT72963A (xx)
IL (1) IL107547A (xx)
LT (1) LT3107B (xx)
LV (1) LV10749B (xx)
MD (1) MD937C2 (xx)
MY (1) MY111373A (xx)
NO (1) NO306760B1 (xx)
NZ (1) NZ257136A (xx)
PL (1) PL172999B1 (xx)
RU (1) RU2108812C1 (xx)
SI (1) SI9300589A (xx)
SK (1) SK280185B6 (xx)
WO (1) WO1994010999A1 (xx)
YU (1) YU71293A (xx)
ZA (1) ZA938413B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4446600A1 (de) * 1994-12-24 1996-06-27 Lohmann Therapie Syst Lts Transdermale Resorption von Wirkstoffen aus unterkühlten Schmelzen
DE19828273B4 (de) * 1998-06-25 2005-02-24 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System, enthaltend Hormone und Kristallisationsinhibitoren
DE19923551A1 (de) * 1999-05-21 2000-11-30 Lohmann Therapie Syst Lts Pharmazeutisches Präparat mit dem Wirkstoff Diamorphin und seine Verwendung in einem Verfahren zur Behandlung der Opiatsucht
AT500143A1 (de) * 2004-04-22 2005-11-15 Sanochemia Pharmazeutika Ag Cholinesterase-inhibitoren in liposomen sowie deren herstellung und verwendung

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3921363A (en) 1974-05-17 1975-11-25 Preston Metal & Roofing Prod Cross member with end connector
DE3528979A1 (de) 1984-08-14 1986-02-27 State Of Israel Represented By The Prime Minister's Office Israel Institute For Biological Research, Ness-Ziona Arzneimittelfreigabesystem
DE3606892A1 (de) 1985-03-05 1986-09-18 Ciba-Geigy Ag, Basel Pharmazeutische formulierungen und verfahren zur behandlung von gedaechtnisstoerungen
DE3843238C1 (xx) 1988-12-22 1990-02-22 Lohmann Therapie Syst Lts
DE3843239C1 (xx) 1988-12-22 1990-02-22 Lohmann Therapie Syst Lts
WO1991015176A1 (en) 1990-04-06 1991-10-17 Pharmetrix Corporation Device and method for enhanced administration of physostigmine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5350581A (en) * 1989-12-14 1994-09-27 Pharmetrix Corporation Method for manufacturing transdermal devices
NZ237241A (en) * 1990-03-02 1993-11-25 Pharmetrix Corp Method for increasing the storage stability of physostigmine
JP4355469B2 (ja) * 2002-03-08 2009-11-04 日本碍子株式会社 アルミナ担持担体、触媒体及びアルミナ担持担体の製造方法

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3921363A (en) 1974-05-17 1975-11-25 Preston Metal & Roofing Prod Cross member with end connector
DE3528979A1 (de) 1984-08-14 1986-02-27 State Of Israel Represented By The Prime Minister's Office Israel Institute For Biological Research, Ness-Ziona Arzneimittelfreigabesystem
DE3528979C2 (xx) 1984-08-14 1989-12-07 State Of Israel Represented By The Prime Minister's Office Israel Institute For Biological Research, Ness-Ziona, Il
DE3606892A1 (de) 1985-03-05 1986-09-18 Ciba-Geigy Ag, Basel Pharmazeutische formulierungen und verfahren zur behandlung von gedaechtnisstoerungen
DE3843238C1 (xx) 1988-12-22 1990-02-22 Lohmann Therapie Syst Lts
DE3843239C1 (xx) 1988-12-22 1990-02-22 Lohmann Therapie Syst Lts
WO1991015176A1 (en) 1990-04-06 1991-10-17 Pharmetrix Corporation Device and method for enhanced administration of physostigmine

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
HEILMANN KLAUS: "Terapinės sistemos"
VOIGT RUDOLF: "Lehrbuch der pharmazeutischen Technologie", pages: 352

Also Published As

Publication number Publication date
RU2108812C1 (ru) 1998-04-20
NO951864L (no) 1995-05-11
WO1994010999A1 (de) 1994-05-26
FI952269A (fi) 1995-05-10
CA2147274C (en) 2005-12-13
KR100254573B1 (ko) 2000-05-01
GR3024720T3 (en) 1997-12-31
IL107547A (en) 1996-12-05
MD940311A (en) 1998-03-31
AU684256B2 (en) 1997-12-11
DE4238223C1 (de) 1994-05-26
IL107547A0 (en) 1994-02-27
ZA938413B (en) 1994-06-09
JPH08502986A (ja) 1996-04-02
SK59395A3 (en) 1996-05-08
MY111373A (en) 1999-12-31
ATE156356T1 (de) 1997-08-15
YU71293A (sh) 1996-07-24
CZ124495A3 (en) 1996-01-17
CA2147274A1 (en) 1994-05-26
HU9501390D0 (en) 1995-06-28
EE03135B1 (et) 1998-12-15
SK280185B6 (sk) 1999-09-10
DK0667774T3 (da) 1998-03-23
ES2105334T3 (es) 1997-10-16
LV10749B (en) 1996-06-20
MD937B2 (xx) 1998-03-31
EG20527A (en) 1999-06-30
NZ257136A (en) 1996-07-26
LTIP1469A (en) 1994-06-15
NO951864D0 (no) 1995-05-11
HUT72963A (en) 1996-06-28
NO306760B1 (no) 1999-12-20
JP3407073B2 (ja) 2003-05-19
PL308531A1 (en) 1995-08-21
HRP931391A2 (en) 1995-02-28
CN1088457A (zh) 1994-06-29
AU5338594A (en) 1994-06-08
FI952269A0 (fi) 1995-05-10
CZ284008B6 (cs) 1998-07-15
EP0667774A1 (de) 1995-08-23
DE59307089D1 (de) 1997-09-11
PL172999B1 (pl) 1998-01-30
SI9300589A (en) 1994-06-30
US5698216A (en) 1997-12-16
HRP931391B1 (en) 1999-12-31
MD937C2 (ro) 1999-01-31
LV10749A (lv) 1995-08-20
KR950703948A (ko) 1995-11-17
EP0667774B1 (de) 1997-08-06

Similar Documents

Publication Publication Date Title
KR950015058B1 (ko) 활성 성분으로 피소스티그민을 함유하는 경피 치료 시스템 및 그 제조방법
RU2176499C2 (ru) Композиция для чрескожного введения стероидных лекарственных средств и содержащий ее препарат
KR100300477B1 (ko) 활성성분으로서 갈란타민을 포함하는 경피치료시스템
KR960006859B1 (ko) 티로시나제 저해 활성을 갖는 약물의 안정성을 개선하는 방법
US8962014B2 (en) Transdermal therapeutic system for administering rivastigmine or derivatives thereof
US20050187212A1 (en) Pharmaceutical composition for topical delivery of meloxicam
HRP930675A2 (en) Process for the production of a transdermal therapeutic system containing buprenorphine as an active component
NZ209843A (en) Transdermal delivery system for administration of nitroglycerin
IL176112A (en) Skin-containing preparation through the stomach containing gastodone and carrier, a medical system for the administration through the skin containing gastodon and a kit
LT3107B (en) Transdermal therapeutical system containing fizostigmine and preparation the same
WO2021098791A1 (zh) 一种含有美金刚的透皮贴剂
JP3980634B2 (ja) 活性物質モルフィン−６−グルクロニドを含む全身的経皮投与用医薬組成物
US10076502B2 (en) Transdermal therapeutic system for administering rivastigmine or derivatives thereof
JPH0753671B2 (ja) 経皮・経粘膜製剤
JPH02196714A (ja) 経皮吸収貼付剤
EP0544900A1 (en) Transdermal nicotine absorption dosage unit and process
JPH02102656A (ja) 経皮吸収貼付剤
JP2001278782A (ja) 二層型経皮吸収製剤
DK202201037A1 (en) Slow-release medical plaster
WO1999032094A1 (en) Compositions for the transdermal and dermal administration of biologically active agents

Legal Events

Date Code Title Description
MM9A Lapsed patents

Effective date: 20011112